Oracle Pharmaceutical vulnerabilities

2 CVEs affecting Oracle Pharmaceutical, 0 known to be exploited (CISA KEV), with EPSS scores. Latest: CVE-2006-5374, published 2006-10-18.

More from Oracle.

Highest priority

Known exploited (CISA KEV) first, then by EPSS exploit probability.

• CVE-2006-1884, published 2006-04-20. High severity, CVSS 10.0. EPSS: 4.6% chance of exploitation in the next 30 days. Unspecified vulnerability in the Oracle Thesaurus Management System component in Oracle E-Business Suite and OPA 4.5.2 Applications has unknown impact and attack vectors, aka Vuln# OPA01.
• CVE-2006-5374, published 2006-10-18. High severity, CVSS 10.0. EPSS: 4.2% chance of exploitation in the next 30 days. Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.